Use of biologic nanolipoprotein particles containing monophosphoryl lipid A as a novel intranasal vaccine platform for Bacillus anthracis

• Published in: The Journal of immunology (1950) Vol. 196; no. 1_Supplement; pp. 145 - 145.3
• Main Authors: Weilhammer, Dina R, Dunkle, Alexis D, Blanchette, Craig, Boone, Tyler, Gilmore, Sean, Corzett, Michele, Fischer, Nicholas, Lehmann, Doerte, Lychak, Cheri, Hoeprich, Paul, Driks, Adam, Rasley, Amy
• Format: Journal Article
• Language: English
• Published: 01.05.2016

Abstract There is considerable interest in developing a novel Bacillus anthracis vaccine that improves upon the shortcomings of the licensed vaccine for broader, more rapid protection of the population. Ideally, a vaccine would recognize the spore in addition to having anti-toxin effects as well as...